RU94031210A - Новые простые эфиры на основе бутилированного гидрокси толуола, их получение, фармацевтическая композиция и способ лечения липидемии и атеросклероза - Google Patents

Новые простые эфиры на основе бутилированного гидрокси толуола, их получение, фармацевтическая композиция и способ лечения липидемии и атеросклероза

Info

Publication number
RU94031210A
RU94031210A RU94031210/04A RU94031210A RU94031210A RU 94031210 A RU94031210 A RU 94031210A RU 94031210/04 A RU94031210/04 A RU 94031210/04A RU 94031210 A RU94031210 A RU 94031210A RU 94031210 A RU94031210 A RU 94031210A
Authority
RU
Russia
Prior art keywords
atherosclerosis
toluena
bottled
hydroxy
recovery
Prior art date
Application number
RU94031210/04A
Other languages
English (en)
Other versions
RU2120938C1 (ru
Inventor
Р.Гольд Маркус
Ярглис Панайиотис
Юнглас Хайнц
Х.Ляймнер Юрген
Петери Деже
П.Квак Гюнтер
Штромайер Йозеф
М.Вюльфрот Петра
Original Assignee
Мерц унд Ко., ГмбХ унд Ко.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/810,214 external-priority patent/US5254549A/en
Application filed by Мерц унд Ко., ГмбХ унд Ко. filed Critical Мерц унд Ко., ГмбХ унд Ко.
Publication of RU94031210A publication Critical patent/RU94031210A/ru
Application granted granted Critical
Publication of RU2120938C1 publication Critical patent/RU2120938C1/ru

Links

Claims (1)

  1. Предложены фармацевтически активные БГТ--ω-пиридиловые эфиры формулы I
    Figure 00000001

    где
    Figure 00000002

    m = 1, 3, причем при m = 1 Σ = 6-9, а при m = 3 S = 5-11, сумма S = [m + n + 1 (для кислорода)], где связь между двумя атомами углерода фрагмента (CH<Mv>p<D>)<Mv>n<D>, соседнего с пиридиновым кольцом, является простой, двойной или тройной, а величина p принимает значения О, 1 или 2 в зависимости от типа связи, и их фармацевтически приемлемые кислотно-аддитивные соли, фармацевтические композиции на их основе и способ лечения липидемии и атеросклероза с их использованием.
RU94031210A 1991-12-19 1992-12-18 ω- ПИРИДИЛОВЫЕ ЭФИРЫ БУТИЛИРОВАННОГО ГИДРОКСИТОЛУОЛА, СПОСОБ ИХ ПОЛУЧЕНИЯ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ЛЕЧЕНИЯ ГИПЕРЛИПИДЕМИИ И АТЕРОСКЛЕРОЗА RU2120938C1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/810,214 US5254549A (en) 1991-12-19 1991-12-19 New BHT ether compounds and their use as hypolipidemic and antiatherosclerotic drugs
US810,214 1991-12-19
US810214 1991-12-19

Publications (2)

Publication Number Publication Date
RU94031210A true RU94031210A (ru) 1996-03-20
RU2120938C1 RU2120938C1 (ru) 1998-10-27

Family

ID=25203281

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94031210A RU2120938C1 (ru) 1991-12-19 1992-12-18 ω- ПИРИДИЛОВЫЕ ЭФИРЫ БУТИЛИРОВАННОГО ГИДРОКСИТОЛУОЛА, СПОСОБ ИХ ПОЛУЧЕНИЯ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ЛЕЧЕНИЯ ГИПЕРЛИПИДЕМИИ И АТЕРОСКЛЕРОЗА

Country Status (16)

Country Link
US (1) US5254549A (ru)
EP (1) EP0619807A1 (ru)
JP (1) JPH07502271A (ru)
AU (1) AU662193B2 (ru)
CA (1) CA2085687A1 (ru)
CZ (1) CZ283456B6 (ru)
FI (1) FI942908A0 (ru)
HU (1) HU215844B (ru)
IL (1) IL104123A (ru)
MX (1) MX9207427A (ru)
NO (1) NO301473B1 (ru)
PL (1) PL171225B1 (ru)
RU (1) RU2120938C1 (ru)
TW (1) TW221289B (ru)
WO (1) WO1993012089A1 (ru)
ZA (1) ZA929867B (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5677291A (en) * 1993-12-10 1997-10-14 Hoechst Marion Roussel, Inc. Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
US5627172A (en) * 1994-03-04 1997-05-06 Natural Supplement Association, Incorporated Method for reduction of serum blood lipids or lipoprotein fraction
US5795876A (en) * 1996-04-30 1998-08-18 Hoechst Marion Rousssel, Inc. Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2, 6-di-alkyl-4-silyl-phenols
US5608095A (en) * 1996-04-30 1997-03-04 Hoechst Marion Roussel, Inc. Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents
US6114572A (en) * 1996-11-20 2000-09-05 Hoechst Marion Roussel, Inc. Substituted phenols and thiophenols useful as antioxidant agents
US6121463A (en) * 1997-06-24 2000-09-19 Hoechst Marion Roussel, Inc. Alkyl-4-silylheterocyclic phenols and thiophenols useful as antioxidant agents
US6133467A (en) * 1997-06-25 2000-10-17 Hoechst Marion Roussel, Inc. 2,6-di-t-butyl-4-[(dimethyl-4-methoxyphenylsilyl)-methyl-oxy]phenol and 2,6-di-t-butyl-4-[(dimethyl-2-methoxy-phenylsilyl)methyloxy]phenol
US6475526B1 (en) 2001-06-05 2002-11-05 Jeffrey B. Smith Zinc containing compositions for anti-viral use
US20080274209A1 (en) * 2002-11-04 2008-11-06 Integritas Pharma, Inc. Methods of treating inflammation
US6855341B2 (en) * 2002-11-04 2005-02-15 Jeffrey B. Smith Anti-viral compositions and methods of making and using the anti-viral compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE271625C (ru) *
JPS52125170A (en) * 1976-04-12 1977-10-20 Yoshitomi Pharmaceut Ind Ltd Pyridine derivatives
DE3431004A1 (de) * 1984-08-23 1986-03-06 Hoechst Ag, 6230 Frankfurt Neue 3-pyridylverbindungen und verfahren zu ihrer herstellung

Similar Documents

Publication Publication Date Title
JPS56139423A (en) Hemostatic agent for dental oral use
EP0786458A3 (en) Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
DE69005247D1 (de) Orale Präparate gegen Zahnbeläge.
ATE142104T1 (de) Nichtirritierende zahnpasta
IL75337A (en) Polyenoic acids omega-substituted by a 4,5-dimethoxy-2-methyl-quinone or a 4,5-dimethoxy-2-methyl-phenyl group,process for the preparation thereof and pharmaceutical compositions containing the same
RU94031210A (ru) Новые простые эфиры на основе бутилированного гидрокси толуола, их получение, фармацевтическая композиция и способ лечения липидемии и атеросклероза
MY102980A (en) Transdermal flux enhancing compositions
KR860006464A (ko) 6-티오크산틴 유도체
FI940696A0 (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
ES8401960A1 (es) Procedimiento para la preparacion de imidazolilfenil-tetrahidropiridazinas.
ES8502116A1 (es) Un compuesto de pirazolpiridina.
WO1991018606A3 (en) Orally active nonaddicting analgesics
FR2455609A1 (fr) 24-24-difluoro-25-hydroxycholecalciferol
AU5495886A (en) 5-fluorobenzonitrile derivatives and pharmacologically acceptable acid addition salts thereof for increasing the lean meat to fat ratio, and/or enhancing the growth rate of warm-blooded animals
ATE1442T1 (de) Pharmazeutisches mittel, enthaltend all-e- oder 13-z-7,8-dehydro-retinsaeure und verfahren zu seiner herstellung.
FR2433506A1 (fr) Derives de 2-acyl-6-aminomethylphenol et procede permettant leur preparation
EP0254534A3 (en) Erythromycin derivatives and compositions and use for inhibiting virus replication and disease
BE1003067A5 (fr) Derives de la pyrimidine.
GB1498919A (en) Furanose-o-pyridylcarboxylic acid esters
AU3391393A (en) Dioxolane derivatives
GB1503626A (en) Substituted piperazine derivative its preparation and compositions containing it
DK0888112T3 (da) Anvendelse af ammoniumforbindelser og/eller urinstof
JPS5233662A (en) Preparation of n2-naphthalenesulfonyl-alginamides and acid addition sa lts thereof
JPS5427571A (en) Preparation of piperidine derivatives
ES8305379A1 (es) Procedimiento para preparar carbotioatos de andorstano.